Phase 3Not yet recruiting
A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid in Patients With Hyperlipidemia Not Adequately Controlled by Statins
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd. (Industry)
- Enrolment
- 222 planned
- Conditions
- Primary Hyperlipidemia
- Interventions
- Bempedoic Acid Tablet; Placebo
- Ages
- adults, older adults
- Registry
- NCT07623915
Full record on ClinicalTrials.gov
From the registry
This trial is a multicenter randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
Primary outcomes
- Percentage change from baseline in LDL-C levels at Week 12
History
Study completion expected
Primary completion expected
Started
Registered